menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

How GoodRx CEO Wendy Barnes is trying to halve the cost of GLP-1 obesity drugs

10 1
19.08.2025
Also: All the news and watercooler chat from Fortune.

© Fortune